Clinical trial · Observational
Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma
NCT07585032CI-TRIAL-00111417EUSRFAINSUrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Transcutaneous and EUS-guided radiofrequency ablation are both modern modalities to apply in the managemnet of various malignancies. In the current study the investigators aim to study the technical feasibility, patient safety and clinical efficacy of EUS-RFA for the treatment of pancreatic insulinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Insulinoma; Pancreas | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EUS-RFA | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Prospective cohort subjected to EUS-RFA
- description
- All patientens enrolled prospectively from 2025 and onwards subjected to EUS-RFA as treatemtn for pancreatic insulinoma
- interventionNames
- Procedure: EUS-RFA
- label
- Control group
- description
- All patients subjected to surgery due to insulinoma during 2018-2024 acting as a historic control group
Primary outcomes (1)
- measure
- Clinical efficacy
- timeFrame
- 3-24 months post-EUS
- description
- Symptom-free survival after EUS-RFA (no clinical signs of residual disease, i.e. insulin-producing insulinoma cells)
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Insulinoma verified by pathology (often from EUS-FNB-sampling) Exclusion Criteria: * Patients unwilling to participate * Patients unable to understand and obtain written informed conscent * Severe comorbidity
References
Publications (0)
Data not yet available
No reference posted for this study.